“Our results suggest that oscillometry . . . may serve as valuable, noninvasive biomarkers for early detection, risk stratification, and longitudinal monitoring of IPF,” the authors concluded.

Two technology leaders, Dario Amodei, CEO of Anthropic, and Nandan Nilekani, co-founder and chairman of Infosys, on how AI’s promise will ultimately hinge on diffusion, not just innovation.

Italy: A new cross-sectional study published in Respiratory Research has highlighted a significant association between vertebral fractures and impaired lung function in patients with ...

A new risk stratification model for idiopathic pulmonary fibrosis could shift treatment from passive monitoring to active, goal-oriented care.

Regulatory officials have granted Molbreevi priority review and assigned a goal date of Aug. 22, 2026. If approved, Molbreevi will be priced between $400,000 and $500,000 per year.

UN chief Antonio Guterres warned technology leaders Thursday of the risks of artificial intelligence, saying its future cannot be left to "the whims of a few billionaires". Speaking at a global AI ...

The allocation of $2.7 billion to three nuclear fuel developers by the Trump administration will revitalize the U.S. uranium enrichment industry and help ease potential nuclear fuel shortages for ...

Allies say McConnell has secured more than $60 billion in direct funding for Kentucky in his 40-plus years in the U.S. Senate ...

A rare physiological case study shows how aerobic capacity, muscle adaptation, and oxygen use can remain remarkably intact well into the eighties.

As artificial intelligence reshapes geopolitics, economies and democratic processes, one reality is becoming impossible to ignore: AI is no longer just a technology conversation. It is a power ...

Alger Small Cap Focus Fund reviews Q4 2025 performance and the impact of the artificial intelligence capital cycle. Read the full analysis for more details.